Disease susceptibility and responsiveness to treatment vary among individuals. To understand this diversity, it is crucial to investigate clinical materials and information from large sets of individuals, such as data that can be obtained from biobanks. BioBank Japan is one of the largest biobanks in East Asia and has a complementary role to biobanks from other populations, such as the UK Biobank, given the presence of diverse ethnic variations.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Nagai, A. et al. J. Epidemiol. 27, 2–8 (2017).
Roselli, C. et al. Nat. Genet. 50, 1225–1233 (2018).
Locke, A. E. et al. Nature 518, 197–206 (2015).
Fujii, R. et al. Circ. Genom. Precis. Med. https://doi.org/10.1161/CIRCGEN.121.003612 (2022).
Imai, K. et al. Am. Polit. Sci. Rev. 105, 765789 (2011).
Sato, N. et al. BMC Med. 19, 260 (2021).
Smith, G. D. et al. Int. J. Epidemiol. 32, 1–22 (2003).
Yang, F. et al. Nutr. Metab. Cardiovasc. Dis. 32, 1266–1274 (2022).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Tanaka, T., Nagata, Y. & Takemoto, A. Integrating biomedical and clinical data with BioBank Japan. Nat Cardiovasc Res 1, 597–598 (2022). https://doi.org/10.1038/s44161-022-00105-w
Published:
Issue Date:
DOI: https://doi.org/10.1038/s44161-022-00105-w